文献速递腹部介入CTMR

结直肠癌肝转移射频消融:CT与MR引导10年随访对比研究

CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance.
PubMed 文献 · Eur Radiol · 2023-12-02

该观察性、回顾性、多中心研究纳入238例患者共496个结直肠癌肝转移灶,比较CT引导与MR引导射频消融的10年随访结果。MR组局部复发率4.6%显著低于CT组20.1%(p<0.001),但两组患者生存无显著差异,中位总生存2.6年。

要点

  • MR引导组局部复发率4.6%显著低于CT引导组20.1%(p<0.001)。
  • 两组技术成功率与技术有效率相近,CT组分别为88%/93%和97.1%/98.6%,MR组为87%/89.6%和98.7%/99.3%。
  • 两组患者生存无显著差异,1年、5年、10年生存率分别为85.9%、25.5%、19.1%。

核心结论

  • MR引导射频消融对结直肠癌肝转移的局部控制显著优于CT引导,但两组患者生存无显著差异。

研究设计与样本

  • 观察性、回顾性、多中心研究,共238例患者496个结直肠癌肝转移灶接受射频消融,CT组143例、MR组77例,18例接受两种方式消融,所有消融灶均用诊断性MRI评估和随访。

诊断标准与关键数值

  • 患者水平技术成功率CT组88%、MR组87%,病灶水平技术成功率CT组93%、MR组89.6%;患者水平技术有效率CT组97.1%、MR组98.7%,病灶水平技术有效率CT组98.6%、MR组99.3%。

临床应用与阅片要点

  • 首次消融后局部复发(原发通畅)CT组20.1% vs MR组4.6%(p<0.001),MR组局部控制更优。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the results of CT- vs MR-guided radiofrequency ablation (RFA) of liver metastases (LM) from colorectal cancer after 10 years of follow-up in an observational, retrospective, and multicentric study.

METHODS: A total of 238 patients with 496 LM were treated with RFA either with CT (CT group) or magnetic resonance (MR group) guidance. Every ablated LM was assessed and followed up with diagnostic MRI. Technical success, technique efficacy, predictive factors, recurrence rates, and overall survival were assessed.

RESULTS: The CT group comprised 143 patients and the MR group 77 patients. Eighteen patients underwent ablation with both modalities. Technical success per patient and per lesion was 88% and 93% for CT and 87% and 89.6% for MR, and technique efficacy was 97.1% and 98.6% for CT and 98.7% and 99.3% for MR respectively. Local recurrence following the first ablation (primary patency) occurred in 20.1% (CT) vs 4.6% (MR) (p < 0.001). Residual liver tumor, size of LM, and advanced N and M stage at initial diagnosis were independent predictors for overall survival in both groups. The median overall survival measured from first RFA treatment was 2.6 years. The 1-year, 5-year, and 10-year survival were 85.9%, 25.5%, and 19.1% respectively.

CONCLUSIONS: The MR group had significantly better local control compared to the CT group. There was no significant difference in patient survival between the two groups.

CLINICAL RELEVANCE STATEMENT: MR-guided radiofrequency ablation of colorectal liver metastases is safe and effective, and offers better local control than CT-guided ablation.

KEY POINTS: • Imaging modality for radiofrequency ablation guidance is an independent predictor of local recurrence in colorectal liver metastases. • MR-guided radiofrequency ablation achieved better local control of liver metastases from colorectal cancer than CT-guided. • The number and size of liver metastases are, among others, independent predictors of survival. Radiofrequency ablation with MR guidance improved clinical outcome but does not affect survival.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Pereira PL, Siemou P, Rempp HJ, et al. CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance. Eur Radiol. 2023. PMID: 38041717. doi:10.1007/s00330-023-10270-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。